Recent advances in systemic therapy for hepatocellular carcinoma

被引：154

作者：

Zhang, Huajun ^{[1
]}

Zhang, Wuyang ^{[2
]}

Jiang, Longying ^{[1
,3
]}

Chen, Yongheng ^{[1
,4
]}

机构：

[1] Cent South Univ, Xiangya Hosp, Dept Oncol, NHC,Key Lab Canc Prote,Lab Struct Biol, Changsha 410008, Hunan, Peoples R China

[2] Cent South Univ, Xiangya Hosp, Clin Skills Training Ctr, Changsha 410008, Hunan, Peoples R China

[3] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China

[4] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Hunan, Peoples R China

来源：

BIOMARKER RESEARCH | 2022年 / 10卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Hepatocellular carcinoma; Molecular targeted therapy; Immunotherapies; Combination; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED MACROPHAGES; RECEPTOR TYROSINE KINASES; NIVOLUMAB PLUS IPILIMUMAB; PHASE-III; DOUBLE-BLIND; OPEN-LABEL; T-CELLS; 1ST-LINE TREATMENT; ANTITUMOR-ACTIVITY;

D O I：

10.1186/s40364-021-00350-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hepatocellular carcinoma (HCC) is one of the most common and lethal malignant tumors in the world. Therapeutic options for advanced HCC are limited. Systemic treatment, especially with conventional cytotoxic drugs, is usually ineffective. For more than a decade, sorafenib has been the only systemic drug that has been proven to be clinically effective for treating advanced HCC. However, over the past three years, the rapid progress of molecular targeted therapies has dramatically changed the treatment landscape for advanced HCC. Immune checkpoint therapies are now being incorporated into HCC therapies, and their combination with molecular targeted therapy is emerging as a tool to enhance the immune response. In this review, we summarize the development and progress of molecular targeted agents and immunotherapies in HCC.

引用

页数：21

共 154 条

[61] Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma [J].

Huang, Lingyuan ;

Zhao, Chanjuan ;

Sun, Kai ;

Yang, Dandan ;

Yan, Linxia ;

Luo, Dan ;

He, Jinli ;

Hu, Xuemei ;

Wang, Rong ;

Shen, Xiaofei ;

Xiao, Ning ;

Zhong, Zhendong .

CELL BIOCHEMISTRY AND FUNCTION, 2020, 38 (05) :541-548

[62] Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues [J].

Hughes, SE .

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1997, 45 (07) :1005-1019

[63] Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib [J].

Iavarone, Massimo ;

Cabibbo, Giuseppe ;

Biolato, Marco ;

Della Corte, Cristina ;

Maida, Marcello ;

Barbara, Marco ;

Basso, Michele ;

Vavassori, Sara ;

Craxi, Antonio ;

Grieco, Antonio ;

Camma, Carlo ;

Colombo, Massimo .

HEPATOLOGY, 2015, 62 (03) :784-791

[64] Field-Practice Study of Sorafenib Therapy for Hepatocellular Carcinoma: A Prospective Multicenter Study in Italy [J].

Iavarone, Massimo ;

Cabibbo, Giuseppe ;

Piscaglia, Fabio ;

Zavaglia, Claudio ;

Grieco, Antonio ;

Villa, Erica ;

Camma, Calogero ;

Colombo, Massimo ;

Sangiovanni, Angelo ;

Vavassori, Sara ;

Romeo, Raffaella ;

Di Marco, Vito ;

Craxi, Antonio ;

Borghi, Alberto ;

Granito, Alessandro ;

Bolondi, Luigi ;

Airoldi, Aldo ;

Pinzello, Giovambattista ;

Biolato, Marco ;

Racco, Simona ;

Pompili, Maurizio ;

Lei, Barbara ;

De Maria, Nicola .

HEPATOLOGY, 2011, 54 (06) :2055-2063

[65] An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors [J].

Ishiguro, Takahiro ;

Sano, Yuji ;

Komatsu, Shun-ichiro ;

Kamata-Sakurai, Mika ;

Kaneko, Akihisa ;

Kinoshita, Yasuko ;

Shiraiwa, Hirotake ;

Azuma, Yumiko ;

Tsunenari, Toshiaki ;

Kayukawa, Yoko ;

Sonobe, Yukiko ;

Ono, Natsuki ;

Sakata, Kiyoaki ;

Fujii, Toshihiko ;

Miyazaki, Yoko ;

Noguchi, Mizuho ;

Endo, Mika ;

Harada, Asako ;

Frings, Werner ;

Fujii, Etsuko ;

Nanba, Eitaro ;

Narita, Atsushi ;

Sakamoto, Akihisa ;

Wakabayashi, Tetsuya ;

Konishi, Hiroko ;

Segawa, Hiroaki ;

Igawa, Tomoyuki ;

Tsushima, Takashi ;

Mutoh, Hironori ;

Nishito, Yukari ;

Takahashi, Mina ;

Stewart, Lorraine ;

ElGabry, Ehab ;

Kawabe, Yoshiki ;

Ishigai, Masaki ;

Chiba, Shuichi ;

Aoki, Masahiro ;

Hattori, Kunihiro ;

Nezu, Junichi .

SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (410)

[66] Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy [J].

Jain, RK .

NATURE MEDICINE, 2001, 7 (09) :987-989

[67] The Role of Endoglin in Hepatocellular Carcinoma [J].

Jeng, Kuo-Shyang ;

Sheen, I-Shyan ;

Lin, Shu-Sheng ;

Leu, Chuen-Miin ;

Chang, Chiung-Fang .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06) :1-12

[68] High Expression of Macrophage Colony-Stimulating Factor-1 Receptor in Peritumoral Liver Tissue Is Associated with Poor Outcome in Hepatocellular Carcinoma After Curative Resection [J].

Jia, Jin-Bin ;

Wang, Wen-Quan ;

Sun, Hui-Chuan ;

Zhu, Xiao-Dong ;

Liu, Liang ;

Zhuang, Peng-Yuan ;

Zhang, Ju-Bo ;

Zhang, Wei ;

Xu, Hua-Xiang ;

Kong, Ling-Qun ;

Lu, Lu ;

Wu, Wei-Zhong ;

Wang, Lu ;

Tang, Zhao-You .

ONCOLOGIST, 2010, 15 (07) :732-743

[69] Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study [J].

Johnson, Philip J. ;

Qin, Shukui ;

Park, Joong-Won ;

Poon, Ronnie T. P. ;

Raoul, Jean-Luc ;

Philip, Philip A. ;

Hsu, Chih-Hung ;

Hu, Tsung-Hui ;

Heo, Jeong ;

Xu, Jianming ;

Lu, Ligong ;

Chao, Yee ;

Boucher, Eveline ;

Han, Kwang-Hyub ;

Paik, Seung-Woon ;

Robles-Avina, Jorge ;

Kudo, Masatoshi ;

Yan, Lunan ;

Sobhonslidsuk, Abhasnee ;

Komov, Dmitry ;

Decaens, Thomas ;

Tak, Won-Young ;

Jeng, Long-Bin ;

Liu, David ;

Ezzeddine, Rana ;

Walters, Ian ;

Cheng, Ann-Lii .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (28) :3517-+

[70] CAR T cell immunotherapy for human cancer [J].

June, Carl H. ;

O'Connor, Roddy S. ;

Kawalekar, Omkar U. ;

Ghassemi, Saba ;

Milone, Michael C. .

SCIENCE, 2018, 359 (6382) :1361-1365

← 2 3 4 5 6 7 8 9 10 11 →